In the News: Companies Combating IV Infiltrations

ivWatch is the only FDA patient monitoring device analyzing data from the tissue surrounding an IV site, detecting IV infiltrations early.

Patient Safety & Quality Healthcare (PSQH) discussed IV infiltration and it’s potential for life-threatening consequences in a recent article. The piece, “Companies Work to Help Combat IV Infiltrations” includes commentary from ivWatch President and CEO, Gary Warren, and cites the ivWatch Model 400 as a clinician partner helping to deliver improved patient care with constant monitoring of the IV site. Read the full article here.

Meet us at NICA | June 21st - June 22nd | **BOOK TODAY**
Meet us at NICA | June 21st - June 22nd | **BOOK TODAY**